
Current Price | $213.35 | Mkt Cap | $55.2B |
---|---|---|---|
Open | $210.50 | P/E Ratio | 20.44 |
Prev. Close | $213.35 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $209.53 - $213.82 | Volume | 1,533,672 |
52-Wk Range | $202.57 - $306.08 | Avg. Daily Vol. | 2,014,902 |
The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.
Current Price | $213.35 | Mkt Cap | $55.2B |
---|---|---|---|
Open | $210.50 | P/E Ratio | 20.44 |
Prev. Close | $213.35 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $209.53 - $213.82 | Volume | 1,533,672 |
52-Wk Range | $202.57 - $306.08 | Avg. Daily Vol. | 2,014,902 |
The best Bull and Bear pitches based on recency and number of recommendations.
Vertex's earnings growth since 2016 as well as its development of non-opioid pain management drugs are reasons to be bullish.
Read the most recent pitches from players about VRTX.
Recs
-Bullishness on gene therapy segment and partnership w/ CRISPR
-Strength in Cystic Fibrosis treatment (Dominant, but large part of US TAM left to capture)
-Research methodology/product development strategy
-Current valuation and multiples. ($55Bn, attractive growth in revenue and net income the past few yrs, plenty of cash on hand)
Recs
Undervalued.
Recs
Developing pills over a shot ,makes them a leader with 60% of people
Find the members with the highest scoring picks in VRTX.
bugeyebear (34.04) Score: +1,125.35
The Score Leader is the player with the highest score across all their picks in VRTX.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
bugeyebear | 34.04 | 3/17/2008 |
![]() |
3Y | $14.60 | +1,361.30% | +235.95% | +1,125.35 | 0 Comment | |
lostontheprairie | 69.75 | 3/12/2008 |
![]() |
5Y | $14.99 | +1,323.28% | +223.08% | +1,100.20 | 0 Comment | |
Kudude | 65.48 | 3/12/2008 |
![]() |
5Y | $14.99 | +1,323.28% | +223.08% | +1,100.20 | 0 Comment | |
Salilp | 76.40 | 3/17/2008 |
![]() |
5Y | $15.07 | +1,315.73% | +238.81% | +1,076.91 | 0 Comment | |
davidmouw2 | < 20 | 3/14/2008 |
![]() |
NS | $15.43 | +1,282.70% | +222.98% | +1,059.71 | 0 Comment | |
![]() |
snazzysnazz | 72.00 | 3/13/2008 |
![]() |
5Y | $15.49 | +1,277.34% | +230.88% | +1,046.46 | 0 Comment |
NovaMechanika | 27.96 | 3/20/2008 |
![]() |
3Y | $15.55 | +1,272.03% | +228.14% | +1,043.89 | 2 Comments | |
stnewbie | 37.77 | 3/12/2008 |
![]() |
NS | $15.78 | +1,252.03% | +224.55% | +1,027.48 | 0 Comment | |
PrincetonAl | 87.72 | 3/7/2008 |
![]() |
3Y | $15.86 | +1,245.21% | +230.82% | +1,014.38 | 1 Comment | |
![]() |
hayrettin | 72.51 | 3/24/2008 |
![]() |
5Y | $16.47 | +1,195.39% | +220.10% | +975.29 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.